Home

Chemed Corp (CHE)

416.57
-48.12 (-10.36%)
NYSE · Last Trade: Jul 30th, 7:46 PM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors

Detailed Quote

Previous Close464.69
Open419.56
Bid400.00
Ask431.76
Day's Range410.00 - 433.81
52 Week Range410.00 - 623.60
Volume522,014
Market Cap6.09B
PE Ratio (TTM)20.30
EPS (TTM)20.5
Dividend & Yield2.000 (0.48%)
1 Month Average Volume196,257

Chart

About Chemed Corp (CHE)

Chemed Inc is a publicly traded company that operates primarily in the healthcare sector, focusing on providing hospice and palliative care services through its subsidiary, VITAS Healthcare. The company is dedicated to improving the quality of life for patients facing terminal illnesses by delivering compassionate care and support to both patients and their families. Additionally, Chemed offers a range of plumbing and drain cleaning services through its Roto-Rooter brand, catering to residential and commercial customers. With a commitment to high standards of service and care, Chemed Inc plays a significant role in the healthcare and home services industries. Read More

News & Press Releases

VITAS® Healthcare Announces CEO Transition and Appointment of New Chief Executive Officer
MIRAMAR, Fla., July 30, 2025 (GLOBE NEWSWIRE) -- VITAS Healthcare, one of the nation’s leading providers of hospice and palliative care, and a subsidiary of Chemed Corporation (NYSE: CHE), today announced that Nicholas M. Westfall will step down as chairman and chief executive officer to pursue other personal and professional opportunities. Joel L. Wherley, president and chief operating officer, was appointed by the Board to succeed Westfall as chief executive officer of VITAS Healthcare.
By VITAS Healthcare · Via GlobeNewswire · July 30, 2025
Why Chemed Stock Is Plummeting Todayfool.com
Chemed missed expectations on both the top and bottom lines with its second-quarter earnings.
Via The Motley Fool · July 30, 2025
Why Chemed (CHE) Stock Is Trading Lower Today
Shares of healthcare services company Chemed Corporation (NYSE:CHE) fell 9% in the afternoon session after the company reported disappointing second-quarter results which missed analysts' EPS and EBITDA estimates. Net income saw a steep 25.9% decline from the prior year's quarter. Chemed pointed to the impact of Medicare Cap billing limitations on its VITAS hospice business as a primary reason for the shortfall. Adding to the concerns, the company also announced the departure of a key executive, the CEO of the VITAS segment.
Via StockStory · July 30, 2025
Earnings Scheduled For July 29, 2025benzinga.com
Via Benzinga · July 29, 2025
Earnings Preview For Chemedbenzinga.com
Via Benzinga · July 28, 2025
Looking Into Chemed's Recent Short Interestbenzinga.com
Via Benzinga · July 18, 2025
Price Over Earnings Overview: Chemedbenzinga.com
Via Benzinga · July 16, 2025
Chemed’s (NYSE:CHE) Q2 Earnings Results: Revenue In Line With Expectations But Stock Drops
Healthcare services company Chemed Corporation (NYSE:CHE) met Wall Street’s revenue expectations in Q2 CY2025, with sales up 3.8% year on year to $618.8 million. Its non-GAAP profit of $4.27 per share was 14.3% below analysts’ consensus estimates.
Via StockStory · July 29, 2025
Chemed Reports Second-Quarter 2025 Results and Announces Executive Management Departure
Chemed Corporation (Chemed) (NYSE: CHE), which operates VITAS Healthcare Corporation (VITAS), one of the nation’s largest providers of end-of-life care, and Roto-Rooter, the nation’s largest commercial and residential plumbing and drain cleaning services provider, reported financial results for its second quarter ended June 30, 2025, versus the comparable prior-year period.
By Chemed Corporation · Via Business Wire · July 29, 2025
Chemed (CHE) Q2 Earnings: What To Expect
Healthcare services company Chemed Corporation (NYSE:CHE) will be reporting results this Tuesday after market hours. Here’s what to expect.
Via StockStory · July 27, 2025
This Palantir Technologies Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Fridaybenzinga.com
Via Benzinga · July 25, 2025
Is the Market Bullish or Bearish on Chemed?benzinga.com
Via Benzinga · June 20, 2025
Is the Market Bullish or Bearish on Chemed?benzinga.com
Via Benzinga · May 21, 2025
$1000 Invested In This Stock 10 Years Ago Would Be Worth This Much Todaybenzinga.com
Via Benzinga · July 15, 2025
1 Oversold Stock Primed to Rebound and 2 to Ignore
The past year hasn't been kind to the stocks featured in this article. Each has tumbled to their lowest points in 12 months, leaving investors to decide whether they're witnessing fire sales or falling knives.
Via StockStory · July 14, 2025
Here's How Much You Would Have Made Owning Chemed Stock In The Last 10 Yearsbenzinga.com
Via Benzinga · July 9, 2025
3 Profitable Stocks with Open Questions
While profitability is essential, it doesn’t guarantee long-term success. Some companies that rest on their margins will lose ground as competition intensifies - as Jeff Bezos said, "Your margin is my opportunity".
Via StockStory · July 4, 2025
Why Chemed (CHE) Shares Are Plunging Today
Shares of healthcare services company Chemed Corporation (NYSE:CHE) fell 14.7% in the afternoon session after the company provided a negative update on its full-year 2025 guidance, citing issues with its VITAS hospice business. 
Via StockStory · June 30, 2025
Crude Oil Moves Lower; Joby Aviation Shares Surgebenzinga.com
Via Benzinga · June 30, 2025
Chemed To Report Second-Quarter 2025 Earnings July 29, 2025
Chemed Corporation (NYSE: CHE) today announced that it will release financial results for the second quarter ended June 30, 2025, on Tuesday, July 29, 2025, following the close of trading on the New York Stock Exchange.
By Chemed Corporation · Via Business Wire · June 27, 2025
Here's How Much $1000 Invested In Chemed 10 Years Ago Would Be Worth Todaybenzinga.com
Via Benzinga · June 17, 2025
1 Cash-Producing Stock Worth Your Attention and 2 to Brush Off
Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it effectively, leading to missed opportunities.
Via StockStory · June 13, 2025
Senior Health, Home Health & Hospice Stocks Q1 In Review: Chemed (NYSE:CHE) Vs Peers
As the Q1 earnings season wraps, let’s dig into this quarter’s best and worst performers in the senior health, home health & hospice industry, including Chemed (NYSE:CHE) and its peers.
Via StockStory · June 8, 2025
3 Healthcare Stocks Skating on Thin Ice
From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. But speed bumps such as inventory destockings have persisted in the wake of COVID-19, and over the past six months, the industry has pulled back by 12.3%. This performance was noticeably worse than the S&P 500’s 1.9% fall.
Via StockStory · June 4, 2025
Here's How Much $100 Invested In Chemed 15 Years Ago Would Be Worth Todaybenzinga.com
Via Benzinga · May 26, 2025